DE60040662D1 - Vektor zur integration von heterologen sequenzen in poxvirusgenomen - Google Patents

Vektor zur integration von heterologen sequenzen in poxvirusgenomen

Info

Publication number
DE60040662D1
DE60040662D1 DE60040662T DE60040662T DE60040662D1 DE 60040662 D1 DE60040662 D1 DE 60040662D1 DE 60040662 T DE60040662 T DE 60040662T DE 60040662 T DE60040662 T DE 60040662T DE 60040662 D1 DE60040662 D1 DE 60040662D1
Authority
DE
Germany
Prior art keywords
sequences
vector
heterologic
integrating
poxvirus genomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040662T
Other languages
English (en)
Inventor
Stefan Wintersperger
Robert Baier
Gerd Sutter
Marion Ohlmann
Volker Erfle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Application granted granted Critical
Publication of DE60040662D1 publication Critical patent/DE60040662D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE60040662T 1999-05-28 2000-05-25 Vektor zur integration von heterologen sequenzen in poxvirusgenomen Expired - Lifetime DE60040662D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900753 1999-05-28
PCT/EP2000/004786 WO2000073476A1 (en) 1999-05-28 2000-05-25 Vector for integration of heterologous sequences into poxviral genomes

Publications (1)

Publication Number Publication Date
DE60040662D1 true DE60040662D1 (de) 2008-12-11

Family

ID=8097154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040662T Expired - Lifetime DE60040662D1 (de) 1999-05-28 2000-05-25 Vektor zur integration von heterologen sequenzen in poxvirusgenomen

Country Status (9)

Country Link
US (2) US6682742B1 (de)
EP (1) EP1180155B1 (de)
JP (2) JP5639736B2 (de)
AT (1) ATE412762T1 (de)
AU (1) AU5397100A (de)
CA (1) CA2372709C (de)
DE (1) DE60040662D1 (de)
DK (1) DK1180155T3 (de)
WO (1) WO2000073476A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP927599A0 (en) * 1999-03-17 1999-04-15 Curtin University Of Technology Tinnitus rehabilitation device and method
ATE412762T1 (de) * 1999-05-28 2008-11-15 Helmholtz Zentrum Muenchen Vektor zur integration von heterologen sequenzen in poxvirusgenomen
DE10143490C2 (de) * 2001-09-05 2003-12-11 Gsf Forschungszentrum Umwelt Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen
AU2007200016B2 (en) * 2002-05-16 2010-04-22 Bavarian Nordic A/S Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of modified vaccinia virus ankara
PL372091A1 (en) * 2002-05-16 2005-07-11 Bavarian Nordic A/S Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
NZ536502A (en) 2002-05-16 2005-10-28 Bavarian Nordic As Recombinant poxvirus expressing homologous genes inserted into the poxviral genome for inducing an immune response in a mammal
US7501127B2 (en) * 2002-05-16 2009-03-10 Bavarian Nordic A/S Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
JP2006515170A (ja) * 2002-11-25 2006-05-25 バヴァリアン・ノルディック・アクティーゼルスカブ 少なくとも２つの牛痘ａｔｉプロモーターを含む組換えポックスウイルス
WO2005048957A2 (en) * 2003-02-20 2005-06-02 Therion Biologics Corporation Novel insertion sites in pox vectors
EP1518932A1 (de) * 2003-09-29 2005-03-30 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Mutierte Form des Modifizierten Vaccinia Virus Ankara (MVA) sowie ihre Verwendung
WO2008076157A2 (en) * 2006-09-08 2008-06-26 Duke University Modified vaccinia ankara virus vaccine
GB201006405D0 (en) 2010-04-16 2010-06-02 Isis Innovation Poxvirus expression system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364773A (en) * 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
AU614064B2 (en) * 1986-09-22 1991-08-22 President of Kyoto University, The Gene for A-type inclusion body of poxvirus
JPH0795956B2 (ja) * 1986-09-22 1995-10-18 京都大学長 ポックスウイルス由来発現制御領域
US5443964A (en) 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
JP2679711B2 (ja) * 1988-02-09 1997-11-19 京都大学長 ボックスウイルスのａ型封入体（ａｔｉ）遺伝子５′上流領域の改良及び当該遺伝子３′下流領域による外来遺伝子発現ベクターの改良
US5997878A (en) * 1991-03-07 1999-12-07 Connaught Laboratories Recombinant poxvirus-cytomegalovirus, compositions and uses
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UA68327C2 (en) * 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
MY150893A (en) 1996-09-24 2014-03-14 Bavarian Nordic As Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
ATE412762T1 (de) * 1999-05-28 2008-11-15 Helmholtz Zentrum Muenchen Vektor zur integration von heterologen sequenzen in poxvirusgenomen

Also Published As

Publication number Publication date
US20040228840A1 (en) 2004-11-18
DK1180155T3 (da) 2009-02-16
EP1180155A1 (de) 2002-02-20
JP2011234731A (ja) 2011-11-24
WO2000073476A1 (en) 2000-12-07
CA2372709A1 (en) 2000-12-07
JP2003501039A (ja) 2003-01-14
US6682742B1 (en) 2004-01-27
US7150874B2 (en) 2006-12-19
EP1180155B1 (de) 2008-10-29
JP5639736B2 (ja) 2014-12-10
CA2372709C (en) 2011-10-25
AU5397100A (en) 2000-12-18
ATE412762T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
DE60040662D1 (de) Vektor zur integration von heterologen sequenzen in poxvirusgenomen
WO2005049844A3 (en) Vectors, mutant viruses and methods for generating mutant viruses
AU4981101A (en) Subtilisin variants
DK0935660T3 (da) Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
YU37502A (sh) Infektivni klonovi
EA200600746A1 (ru) Конструкции нуклеиновых кислот
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
NZ333781A (en) Feline vaccine comprising at least three polynucleotide vaccine valencies each comprising a plasmid integrating a gene with one feline pathogen valency
DK0695361T4 (da) Ekspression af heterologe gener ifølge en målekspressionsprofil
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
DK0917571T3 (da) Hidtil ukendt agoutirelateret gen
HK1076835A1 (en) Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
WO2002006457A3 (en) Novel lipase genes
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
ATE452187T1 (de) Methode zur isolation von nukleinsäuren
WO2002081709A3 (en) Modified hpv e6 and e7 genes and proteins useful for vaccination
DK1356062T3 (da) Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus
DK0543344T3 (da) Mikroorganismer til stabilisering af plasmider
WO2002079409A3 (en) Integrases for the insertion of heterologous nucleic acids into the plastid genome
WO2002081632A3 (en) Nucleic acids for transgene expression
ATE389726T1 (de) Infektiöse vektoren und pflanzenklone, die sich von turnip mosaikvirus herleiten
WO2001011065A3 (en) Hepatitis a virus clones adapted for growth in agmk cells
AU2002349094A1 (en) Hdv nucleic acid molecules, fragments and applications thereof
ATE494380T1 (de) Gebrauch von konstrukten mit rekombinanten sequenzmotifen zur erhöhung der genexpression in moosen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition